BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $137,000 | -67.3% | 43,200 | +11.3% | 0.01% | -50.0% |
| Q4 2021 | $419,000 | -87.9% | 38,800 | -90.1% | 0.01% | -88.0% |
| Q4 2020 | $3,465,000 | +368.9% | 391,600 | +127.8% | 0.10% | +177.8% |
| Q3 2020 | $739,000 | -64.5% | 171,900 | +14.5% | 0.04% | -68.4% |
| Q2 2020 | $2,080,000 | +12135.3% | 150,100 | +63.0% | 0.11% | +11300.0% |
| Q1 2020 | $17,000 | -99.7% | 92,100 | -44.0% | 0.00% | -99.6% |
| Q4 2019 | $5,072,000 | +435.6% | 164,452 | -30.6% | 0.28% | +256.4% |
| Q3 2019 | $947,000 | +25.4% | 236,899 | -24.1% | 0.08% | +34.5% |
| Q2 2019 | $755,000 | +568.1% | 312,300 | +266.5% | 0.06% | +480.0% |
| Q1 2019 | $113,000 | -79.2% | 85,200 | +69.6% | 0.01% | -63.0% |
| Q1 2018 | $542,000 | – | 50,247 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |